SCM
IRWD icon

Sterling Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Sterling Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.75K Sell
1,353
-563
-29% -$2.31K ﹤0.01% 2756
2025
Q4 		$6.46K Buy
1,916
+675
+54% +$1.75K ﹤0.01% 2802
2025
Q3 		$1.63K Buy
1,241
+539
+77% +$558 ﹤0.01% 3010
2025
Q2 		$503 Sell
702
-1,027
-59% -$806 ﹤0.01% 3153
2025
Q1 		$2.54K Sell
1,729
-1,314
-43% -$3.13K ﹤0.01% 2497
2024
Q4 		$13.5K Buy
3,043
+2,670
+716% +$10.8K ﹤0.01% 2021
2024
Q3 		$1.54K Buy
+373
New +$2K ﹤0.01% 2317

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sterling Capital Management's IRWD Position: Q1 2026 in Review

Sterling Capital Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 29% in Q1 2026, selling an estimated $2.31K and leaving 1,353 shares worth $4.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2756.

Sterling Capital Management first reported a position in IRWD in Q3 2024 and has held it in 7 quarters since. The position peaked at $13.5K in Q4 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Sterling Capital Management held 1,353 shares of Ironwood Pharmaceuticals worth $4.75K as of Q1 2026.
  • Sterling Capital Management sold 563 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $2.31K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2756 holding.
  • Sterling Capital Management first reported a position in Ironwood Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Ironwood Pharmaceuticals position peaked at $13.5K in Q4 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.